These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 1323598)

  • 1. Phosphorus-31 magnetic resonance spectroscopy of the human liver using chemical shift imaging techniques.
    Cox IJ; Menon DK; Sargentoni J; Bryant DJ; Collins AG; Coutts GA; Iles RA; Bell JD; Benjamin IS; Gilbey S
    J Hepatol; 1992 Mar; 14(2-3):265-75. PubMed ID: 1323598
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of functional grade and etiology on in vivo hepatic phosphorus-31 magnetic resonance spectroscopy in cirrhosis: biochemical basis of spectral appearances.
    Menon DK; Sargentoni J; Taylor-Robinson SD; Bell JD; Cox IJ; Bryant DJ; Coutts GA; Rolles K; Burroughs AK; Morgan MY
    Hepatology; 1995 Feb; 21(2):417-27. PubMed ID: 7843715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo and in vitro 31P magnetic resonance spectroscopy of focal hepatic malignancies.
    Cox IJ; Bell JD; Peden CJ; Iles RA; Foster CS; Watanapa P; Williamson RC
    NMR Biomed; 1992; 5(3):114-20. PubMed ID: 1322688
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo hepatic 31P magnetic resonance spectroscopy in chronic alcohol abusers.
    Menon DK; Harris M; Sargentoni J; Taylor-Robinson SD; Cox IJ; Morgan MY
    Gastroenterology; 1995 Mar; 108(3):776-88. PubMed ID: 7875480
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship of 31P MR spectroscopy to the histopathological grading of chronic hepatitis and response to therapy.
    Kiyono K; Shibata A; Sone S; Watanabe T; Oguchi M; Shikama N; Ichijo T; Kiyosawa K; Sodeyama T
    Acta Radiol; 1998 May; 39(3):309-14. PubMed ID: 9571950
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Evaluation of biochemical metabolites by 31P MR spectroscopy in leukemic infiltration of liver].
    Sun JZ; Wang ZK; Yu RS; Huang LS; Xu XF; Zhang MM
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2010 Mar; 39(2):150-6. PubMed ID: 20387242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Saturation effects in phosphorus-31 magnetic resonance spectra of the human liver.
    Cox IJ; Coutts GA; Gadian DG; Ghosh P; Sargentoni J; Young IR
    Magn Reson Med; 1991 Jan; 17(1):53-61. PubMed ID: 1906126
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of single-voxel clinical in vivo hepatic 31P MR spectra acquired at 1.5 and 3.0 Tesla in health and diseased states.
    Wylezinska M; Cobbold JF; Fitzpatrick J; McPhail MJ; Crossey MM; Thomas HC; Hajnal JV; Vennart W; Cox IJ; Taylor-Robinson SD
    NMR Biomed; 2011 Apr; 24(3):231-7. PubMed ID: 20949641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The total entropy for evaluating 31P-magnetic resonance spectra of the liver in healthy volunteers and patients with metastases.
    Brinkmann G; Melchert UH; Lalk G; Emde L; Link J; Muhle C; Steffens JC; Heller M
    Invest Radiol; 1997 Feb; 32(2):100-4. PubMed ID: 9039582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The response of the rat liver in situ to bromobenzene--in vivo proton magnetic resonance imaging and 31P magnetic resonance spectroscopy studies.
    Locke SJ; Brauer M
    Toxicol Appl Pharmacol; 1991 Sep; 110(3):416-28. PubMed ID: 1949010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MR imaging and spectroscopy of the basal ganglia in chronic liver disease: correlation of T1-weighted contrast measurements with abnormalities in proton and phosphorus-31 MR spectra.
    Taylor-Robinson SD; Sargentoni J; Oatridge A; Bryant DJ; Hajnal JV; Marcus CD; Seery JP; Hodgson HJ; deSouza NM
    Metab Brain Dis; 1996 Sep; 11(3):249-68. PubMed ID: 8869945
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatic cancers and their response to chemoembolization therapy. Quantitative image-guided 31P magnetic resonance spectroscopy.
    Meyerhoff DJ; Karczmar GS; Valone F; Venook A; Matson GB; Weiner MW
    Invest Radiol; 1992 Jun; 27(6):456-64. PubMed ID: 1318873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Assessment of functional severity on in vivo hepatic 31P-MRS in diffuse hepatic disease: comparative studies with 99mTc-GSA].
    Matoba M; Tonami H; Yokota H; Higashi K; Yamamoto I
    Nihon Igaku Hoshasen Gakkai Zasshi; 2000 Jul; 60(8):439-44. PubMed ID: 10965750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Abnormal phosphomonoester signals in 31P MR spectra from patients with hepatic lymphoma. A possible marker of liver infiltration and response to chemotherapy.
    Dixon RM; Angus PW; Rajagopalan B; Radda GK
    Br J Cancer; 1991 Jun; 63(6):953-8. PubMed ID: 2069850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatic phosphorus-31 magnetic resonance spectroscopy in primary biliary cirrhosis and its relation to prognostic models.
    Jalan R; Sargentoni J; Coutts GA; Bell JD; Rolles K; Burroughs AK; Taylor Robinson SD
    Gut; 1996 Jul; 39(1):141-6. PubMed ID: 8881826
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The relationship between 31P magnetic resonance spectroscopy and the histopathology of livers of chronic viral hepatitis patients].
    Wu B; Song B; Zhou XP; Yang Y; Lei XZ; Jiang LL
    Zhonghua Gan Zang Bing Za Zhi; 2007 May; 15(5):338-41. PubMed ID: 17524264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [31P-MR spectroscopy of liver diseases with reference to variable pulse recovery times].
    Brinkmann G; Melchert UH; Lalk G; Heller M
    Rofo; 1993 Nov; 159(5):412-8. PubMed ID: 8219133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo and in vitro hepatic phosphorus-31 magnetic resonance spectroscopy and electron microscopy in chronic ductopenic rejection of human liver allografts.
    Taylor-Robinson SD; Sargentoni J; Bell JD; Thomas EL; Marcus CD; Changani KK; Saeed N; Hodgson HJ; Davidson BR; Burroughs AK; Rolles K; Foster CS; Cox IJ
    Gut; 1998 May; 42(5):735-43. PubMed ID: 9659173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-alcoholic fatty liver disease: spectral patterns observed from an in vivo phosphorus magnetic resonance spectroscopy study.
    Abrigo JM; Shen J; Wong VW; Yeung DK; Wong GL; Chim AM; Chan AW; Choi PC; Chan FK; Chan HL; Chu WC
    J Hepatol; 2014 Apr; 60(4):809-15. PubMed ID: 24291241
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The relationship of in vivo 31P MR spectroscopy to histology in chronic hepatitis C.
    Lim AK; Patel N; Hamilton G; Hajnal JV; Goldin RD; Taylor-Robinson SD
    Hepatology; 2003 Apr; 37(4):788-94. PubMed ID: 12668971
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.